Abstract

The National Committee for Technology Incorporation (CONITEC) aims to support Ministry of Health in decisions on incorporation, exclusion or modification of technologies in the Brazilian Public Health System (SUS). For this, it produces reports with recommendations with different characteristics. To analyze the CONITEC reports on incorporation, exclusion or modification of health technologies in the SUS. Descriptive study, based on the reports available at the CONITEC website, from July 2012 to April 2015. Reports were classified according to: type of technology, type of applicant, type of report, presence of Health Economic Evaluation (HEE), and the type of HEE. One hundred and thirty two reports were analyzed. The type of technologies most frequently evaluated were: drugs (65.2%), procedures (19.7%) and materials (9.1%). The two major applicants were: Public Health System (51.5%) and pharmaceutical industry (37.1%). The majority of reports were classified as: Description of Technology (40%), Mini Health Technology Assessment (33%), Rapid Review (23%) and only 4% of the reports were Full Health Technology Assessment. One hundred and one reports studies included some economic data, 53.5% (n = 54) were classified as partial HEE and 46.5% (n = 47) were full HEE. Among partial economic evaluation, initial estimates of budget impact analysis was the most frequent (n = 51; 94.4%) and among the full economic evaluations, cost-effectiveness analysis (n = 20; 42.6%). Out of 47 full economic evaluations, 33 (70.2%) presented the incremental cost-effectiveness ratios (ICERs). Of all the analyzed reports (n = 132), only 25% (n = 33) performed a complete HEE with ICER. The type of technologies most frequently evaluated were drugs, and the major applicant was the Public Health System. The majority of the recommendations were based on Technology Description reports, and the most common HEE was initial estimates of budget impact analysis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call